Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO 
Apple Tests China's CXMT Memory Chips as DRAM Maker Gains Global Market Share 
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand 
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge 
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate 
OpenAI GPT-5.6 Set for Wider Release After U.S. Commerce Approval, Report Says 
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO 
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy 
Sino Biopharm Stock Rises After AstraZeneca Licensing Deal, GSK Partnership Expansion 
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow 
Netflix, Disney, YouTube Eye FIFA World Cup TV Rights in Multi-Billion Dollar Battle 
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO 
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal 
Chinese Chip Stocks Jump as Apple Reportedly Tests CXMT Memory Chips for China Devices 
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest 
DUBLIN, IRELAND, May 01, 2018 -- Horizon Pharma plc (NASDAQ:HZNP), today announced that the company will participate in the following conference in May:
UBS Global Healthcare Conference
- Date: May 22, 2018
- Presentation Time: 9:30 a.m. ET
- Location: New York
The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcast will be available for the event.
About Horizon Pharma plc
Horizon Pharma plc is focused on researching, developing and commercializing innovative medicines that address unmet treatment needs for rare and rheumatic diseases. By fostering a growing pipeline of medicines in development and exploring all potential uses for currently marketed medicines, we strive to make a powerful difference for patients, their caregivers and physicians. For us, it’s personal: by living up to our own potential, we are helping others live up to theirs. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter, like us on Facebook or explore career opportunities on LinkedIn.
| Contacts: | |
| Investors: Tina Ventura Senior Vice President, Investor Relations [email protected] | U.S. Media: Geoff Curtis Senior Vice President, Corporate Affairs & Chief Communications Officer [email protected] |
| Ruth Venning Executive Director, Investor Relations [email protected] | Ireland Media: Ray Gordon Gordon MRM [email protected] |
